Not Satisfied With Your Current Migraine Treatment?
If you suffer from migraines, you may qualify for a clinical research study exploring this condition. The SUMMIT Study is evaluating a new investigational medicine for the acute treatment of migraines.
Migraines don’t have to keep you from reaching new heights.
Consider joining the SUMMIT Study today.
You May Be Able to Participate in the SUMMIT Study if you:
✅ Are 18 to 65 years of age
✅ Have had migraines for at least 1 year
✅ Have 2 to 8 migraine attacks each month
✅ Have less than 15 total headache days each month
The investigational medicine is taken as powder that is administered into your nose.
You will receive all study-related care at no cost, and participants may be compensated. Health insurance is not needed.
About Summit Study
The SUMMIT Study will test whether an investigational nasal powder, self-administered via a simple, single-use device, works to improve migraine pain and other symptoms related to migraine.
Migraine can be debilitating and have a negative impact on one’s daily life. Clinical research can help to find safe and effective migraine treatments for everyone.
The study will involve 3 study visits over the course of up to 3 months.
Those who qualify and meet all study eligibility criteria will be trained in the use of the nasal device and in the use of an electronic diary to record their headache attacks.
Approximately 1,400 participants will be enrolled, and participants may be compensated for time and travel.
About Clinical Research
Clinical research studies seek to advance and improve treatment options for all conditions, including migraine.
A clinical research study is designed to answer questions about the safety and effectiveness of potential new drugs. These studies must be performed before a potential new medication or treatment can be approved for use in patients and available to the public.
It is important to test drugs and medical products in the people they are meant to help. Diversity is also important in research, because different people may respond differently to treatments.
For each clinical research study, researchers develop eligibility criteria such as age, gender, previous treatment history, and other medical conditions.
Not everyone who applies for a clinical research study will be eligible to join. Participants will be selected based on the eligibility criteria and the number of participants needed by the researchers.
Taking part in a clinical research study can offer several benefits, including:
✅ Taking an active part in managing your own health.
✅ Having access to breakthrough treatments available.
✅ Having access to the specialists in the condition being studied
✅ Helping others by possibly advancing medical research
Frequently Asked Questions
Studies and research can be confusing. You have the right to ask as many questions as necessary in order to understand the benefits and risks of participating. Below are some FAQs, frequently asked questions in regards to the SUMMIT Study
Who can participate in this clinical research study?
This Clinical research study is evaluating an investigational nasal powder to treat acute migraines in adults. You may be able to take part in this study if you:
✅Are 18 to 65 years of age
✅Have had migraines for at least 1 year
✅Have 2 to 8 migraine attacks each month
✅Have less than 15 total headache days each month
What's involved with Study Participation?
The study will involve 3 visits to the study center, which take place over the course of several months, and will enroll approximately 1,400 participants.
The first visit (Visit 1) is for screening, and the study team will evaluate your eligibility to participate.
If you proceed, you will receive training on the use of the investigational nasal device, use of the electronic diary, and will complete a series of health assessments and laboratory tests.
Training and health assessments will also be part of Visit 2, and if you qualify, you will receive the investigational medicine to take home for use during your next migraine.
Visit 3 is the final visit, and you will complete final study procedures and return study materials such as the used investigational device and e-diary device.
What is the medication being tested?
The study medication is an investigational nasal powder, administered via a pre-filled, single-use electronic device.
How long is this clinical research study?
If eligible, participation can last several months, which includes 3 visits to the study center.
Does participating in this study cost me anything?
There is no cost to you for participating in the study.
What about my current medications ?
Do not discontinue any medication unless you are advised to do so by the study center staff or your primary care physician.
Why did I disqualify?
Clinical research studies are designed in specific ways, and one or more of the answers that you provided were outside of the guidelines for this study. This does not mean you will not qualify for different research studies.
Schedule Your Free Research Consult
To learn more about Summit study and to see if you qualify, just schedule time with our research coordinators. We will be happy to answer any questions you may have.
About Migraines
-
Migraine is a common, but incapacitating, neurological disease that affects approximately 39 million people in the United States alone.
-
Migraine is most common between the ages of 25 and 55.
-
Migraine typically involves a severe throbbing recurring pain, usually on one side of the head.
-
About 90% of migraine sufferers have a family history of migraine.
-
Migraine is the 3rd most prevalent illness in the world.
-
Attacks usually last between 4 and 72 hours.
-
Attacks are often accompanied by one or more of the following: nausea; vomiting; extreme sensitivity to sound, light, touch, and smell; and tingling or numbness of the extremities of the face.
Clinical research can help to find safe and effective migraine treatments for everyone. This is where the SUMMIT Study comes in.
Clinical Research can help to find safe and effective migraine treatments for everyone. This is where SUMMIT Study comes in.
Source: Migraine Research Foundation